Status:
UNKNOWN
Effect of Quercetin Supplementation on Endometriosis Outcomes
Lead Sponsor:
National Nutrition and Food Technology Institute
Collaborating Sponsors:
Shahid Beheshti University of Medical Sciences
Conditions:
Endometriosis
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
Quercetin is a polyphenol compound that possesses anti-inflammatory properties and can be found in various food sources like apples, berries, cabbage, and onions. In Park et al.'s study, it was discov...
Detailed Description
The participants in the study were randomly assigned to two groups: the intervention group and the control group. The intervention group will receive two 500 mg quercetin tablets daily, after breakfas...
Eligibility Criteria
Inclusion
- Willing to cooperate and complete the informed consent form.
- Diagnosed endometriosis using laparoscopy and histopathological tests.
- In the age group of 18 to 40 years.
- Having a regular menstrual cycle.
- Having a body mass index between 18.5 and 30.
Exclusion
- Using hormonal medications or intrauterine treatments for a minimum of three months prior to collecting a sample.
- Having immune system disorders, persistent infections, diabetes, or any conditions like polyps and fibroids within the uterine cavity.
Key Trial Info
Start Date :
August 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05983224
Start Date
August 15 2023
End Date
March 1 2024
Last Update
August 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Nutrition and Food Technology Research Institute
Tehran, Iran